Bioprogress Future2

GH always said it was a billion pound company or it was nothing and although most of what he said has been discredited, I still think he was right. our overheads are now very low. if we can start producing generic drugs in house, as well as commercialise our key technologies to other partners, what level of profits might we expect in 12 months time? Remember, Dexo is already well known in France and the French have a massive, innovative and well funded healthcare regime: will we be able to tap straight into that? We could easily be making several million pounds a year and what p/e ratio would you apply during the period of exponential growth? It doesn't take much for the mind to boggle. A ten bagger from here within 12 months is perfectly feasible, and for long term holders, a dividend well into double figures is perfectly possible within 3-4 years.